Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease

Autor: Penner, G, Lecocq, S, Chopin, A, Vedoya, X, Lista, S, Vergallo, A, Cavedo, E, Lejeune, F, Dubois, B, Hampel, H, Bakardjian, H, Benali, H, Bertin, H, Bonheur, J, Boukadida, L, Boukerrou, N, Chiesa, Pa, Colliot, O, Dubois, M, Epelbaum, S, Gagliardi, G, Genthon, R, Habert, M, Houot, M, Kas, A, Lamari, F, Levy, M, Metzinger, C, Mochel, F, Nyasse, F, Poisson, C, Potier, M, Revillon, M, Santos, A, Andrade, Ks, Sole, M, Surtee, M, de Schotten, Mt, Younsi, N, Afshar, M, Aguilar, Lf, Akman-Anderson, L, Aremas, J, Avila, J, Babiloni, C, Baldacci, F, Batrla, R, Benda, N, Black, Kl, Bokde, Alw, Bonuccelli, U, Broich, K, Cacciola, F, Caraci, F, Caruso, G, Castrillo, J, Ceravolo, R, Corbo, M, Corvol, J, Cuello, Ac, Cummings, Jl, Depypere, H, Duggento, A, Emanuele, E, Escott-Price, V, Federoff, H, Ferretti, Mt, Fiandaca, M, Frank, Ra, Garaci, F, Geerts, H, Giacobini, E, Giorgi, Fs, Goetzl, Ej, Graziani, M, Haberkamp, M, Hanisch, B, Herholz, K, Hernandez, F, Imbimbo, Bp, Kapogiannis, D, Karran, E, Kiddle, Sj, Kim, Sh, Koronyo, Y, Koronyo-Hamaoui, M, Langevin, T, Lehericy, S, Lemercier, P, Llavero, F, Lorenceau, J, Lucia, A, Mango, D, Mapstone, M, Neri, C, Nistico, R, O'Bryant, Se, Palermo, G, Perry, G, Ritchie, C, Rossi, S, Saidi, A, Santarnecchi, E, Schneider, Ls, Sporns, O, Toschi, N, Valenzuela, Pl, Vellas, B, Verdooner, Sr, Villain, N, Giudici, Kv, Watling, M, Welikovitch, La, Woodcock, J, Younesi, E, Zugaza, Jl

Publikováno v: PLoS ONE
PLoS ONE, Public Library of Science, 2021, 16 (1), pp.e0243902. ⟨10.1371/journal.pone.0243902⟩
PloS one, vol 16, iss 1
PLoS ONE, Vol 16, Iss 1, p e0243902 (2021)

International audience; The traditional approach to biomarker discovery for any pathology has been through hypothesis-based research one candidate at a time. The objective of this study was to develop an agnostic approach for the simultaneous screeni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d881581b637d55a202d435939a4af8c
https://hal.sorbonne-universite.fr/hal-03212567/document

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors

Autor: Teipel, Sj, Cavedo, E, Hampel, H, Grothe, Mj, Aguilar, Lf, Babiloni, C, Baldacci, F, Benda, N, Black, Kl, Bokde, Alw, Bonuccelli, U, Broich, K, Bun, Rs, Cacciola, F, Castrillo, J, Ceravolo, R, Chiesa, Pa, Colliot, O, Coman, C, Corvol, J, Cuello, Ac, Depypere, H, Dubois, B, Duggento, A, Durrleman, S, Escott-Price, V, Federoff, H, Ferretti, Mt, Fiandaca, M, Frank, Ra, Garaci, F, Genthon, R, George, N, Giorgi, Fs, Graziani, M, Haberkamp, M, Habert, M, Herholz, K, Karran, E, Kim, Sh, Koronyo, Y, Koronyo-Hamaoui, M, Lamari, F, Langevin, T, Lehericy, S, Lista, S, Lorenceau, J, Mapstone, M, Neri, C, Nistico, R, Nyasse-Messene, F, O'Bryant, Se, Perry, G, Ritchie, C, Rojkova, K, Rossi, S, Saidi, A, Santarnecchi, E, Schneider, Ls, Sporns, O, Toschi, N, Verdooner, Sr, Vergallo, A, Villain, N, Welikovitch, La, Woodcock, J, Younesi, E, Cummings, Jl

Publikováno v: FRONTIERS IN NEUROLOGY
Frontiers in neurology 9, 642 (2018). doi:10.3389/fneur.2018.00642
Frontiers in Neurology
Alzheimer's Disease Neuroimaging Initiative & Alzheimer Precision Medicine Initiative (APMI) 2018, ' Basal forebrain volume, but not hippocampal volume, is a predictor of global cognitive decline in patients with alzheimer's disease treated with cholinesterase inhibitors ', Frontiers in Neurology, vol. 9, no. AUG, 642 . https://doi.org/10.3389/fneur.2018.00642
Frontiers in Neurology, Vol 9 (2018)
Frontiers in neurology, vol 9, iss AUG

Background: Predicting the progression of cognitive decline in Alzheimer's disease (AD) is important for treatment selection and patient counseling. Structural MRI markers such as hippocampus or basal forebrain volumes might represent useful instrume

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b7352746c9d3ff34b360de9c1bf90dd
https://doi.org/10.3389/fneur.2018.00642

Nerve growth factor metabolic dysfunction in Down's syndrome brains

Autor: Iulita, MF, Do Carmo, S, Ower, AK, Fortress, AM, Aguilar, LF, Hanna, M, Wisniewski, T, Granholm, A-C, Buhusi, M, Busciglio, J, Cuello, AC

Publikováno v: Iulita, MF; Do Carmo, S; Ower, AK; Fortress, AM; Aguilar, LF; Hanna, M; et al.(2014). Nerve growth factor metabolic dysfunction in Down's syndrome brains. BRAIN, 137, 860-872. doi: 10.1093/brain/awt372. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8n96h4kx

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::d53596c961e6427a978fca1d41f74194
http://www.escholarship.org/uc/item/8n96h4kx

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.